Citigroup
KZIA

Citigroup’s Kazia Therapeutics KZIA Stock Holding History

Citigroup’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$7 – 6180
2025
Q4 		$7 Sell
1
-638
-100% -$5.44K ﹤0.01% 5839
2025
Q3 		$4.68K Buy
+639
New +$5.3K ﹤0.01% 5249
2025
Q1 		– Sell
-144
Closed -$1.27K – 5785
2024
Q4 		$1.27K Buy
+144
New +$3.33K ﹤0.01% 5579
2022
Q2 		– Sell
-12
Closed -$5K – 6456
2022
Q1 		$5K Buy
+12
New +$4.29K ﹤0.01% 5819
2016
Q2 		– Hold
0
– – – 7240
2016
Q1 		– Sell
-1
Closed -$422 – 7606
2015
Q4 		$0 Sell
1
-2
-67% -$977 ﹤0.01% 7712
2015
Q3 		$2K Sell
3
-6
-67% -$3.89K ﹤0.01% 7028
2015
Q2 		$7K Sell
9
-4
-31% -$4.54K ﹤0.01% 6622
2015
Q1 		$11K Buy
13
+6
+86% +$3.44K ﹤0.01% 6421
2014
Q4 		$3K Buy
+7
New +$3.47K ﹤0.01% 6791
2014
Q3 		– Hold
0
– – – 7185
2014
Q2 		– Hold
0
– – – 7226
2014
Q1 		– Sell
-2
Closed -$1K – 7113
2013
Q4 		$1K Buy
+2
New +$1.93K ﹤0.01% 6863

Other funds holding KZIA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup's KZIA Position: Q1 2026 in Review

Citigroup sold out of Kazia Therapeutics (KZIA) in Q1 2026, closing a stake of 1 share — an estimated $7 sold.

Citigroup first reported a position in KZIA in Q4 2013 and held it in 10 quarters. The position peaked at $11K in Q1 2015. 23 funds tracked by Wall St. Rank hold KZIA as of Q1 2026.

  • Citigroup reported no remaining Kazia Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 1 Kazia Therapeutics share in Q1 2026, an estimated $7.
  • Citigroup first reported a position in Kazia Therapeutics in Q4 2013 and held it in 10 quarters.
  • Citigroup's Kazia Therapeutics position peaked at $11K in Q1 2015.
  • 23 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.